CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Phylogica Limited Company Snapshot
Phylogica Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Phylogica Limited with three other companies in this sector in Australia: Bioxyne Limited (2017 sales of 2.01 million Australian Dollars [US$1.59 million] ), Mesoblast Ltd (3.20 million Australian Dollars [US$2.52 million] of which 100% was Mesenchymal Precursor Cell), and Starpharma Holdings Limited (3.65 million Australian Dollars [US$2.88 million] of which 100% was Dendritic).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Phylogica Limited
  Stock Performance Chart for Phylogica Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): .04
(Figures in Australian Dollars)
1 Week -10.0%   13 Weeks -18.2%  
4 Weeks -14.3%   52 Weeks 111.8%  
 
Phylogica Limited Key Data:
  Ticker: PYC Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,760,258
(Year Ending Jan 2018).
Employees: 24
  Currency: Australian Dollars Market Cap: 76,324,394
  Fiscal Yr Ends: June Shares Outstanding: 2,120,122,067
  Share Type: Ordinary Closely Held Shares: 1,414,794,865
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.